 Paul Awolade
| Title | Research Associate |
|---|
| Institution | University of Colorado Denver - Anschutz Medical Campus |
|---|
| Department | SOP-Administration |
|---|
|
|
|
 Bibliographic
-
Clune S, Awolade P, Zhou Q, Esquer H, Matter B, Kearns JT, Kellett T, Akintayo DC, Kompella UB, LaBarbera DV. The validation of new CHD1L inhibitors as a therapeutic strategy for cancer. Biomed Pharmacother. 2024 Jan; 170:116037. PMID: 38128184.
-
Cele N, Awolade P, Seboletswe P, Olofinsan K, Islam MS, Singh P. a-Glucosidase and a-Amylase Inhibitory Potentials of Quinoline-1,3,4-oxadiazole Conjugates Bearing 1,2,3-Triazole with Antioxidant Activity, Kinetic Studies, and Computational Validation. Pharmaceuticals (Basel). 2022 Aug 22; 15(8). PMID: 36015183.
-
Prigaro BJ, Esquer H, Zhou Q, Pike LA, Awolade P, Lai XH, Abraham AD, Abbott JM, Matter B, Kompella UB, Messersmith WA, Gustafson DL, LaBarbera DV. Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L. J Med Chem. 2022 03 10; 65(5):3943-3961. PMID: 35192363.
-
Ebenezer O, Bodede O, Awolade P, Jordaan MA, Ogunsakin RE, Shapi M. Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis. Acta Pharm. 2022 Jun 01; 72(2):199-224. PMID: 36651508.
-
Kumar V, Dhawan S, Girase PS, Awolade P, Shinde SR, Karpoormath R, Singh P. Recent Advances in Chalcone-Based Anticancer Heterocycles: A Structural and Molecular Target Perspective. Curr Med Chem. 2021 Oct 25; 28(33):6805-6845. PMID: 33749549.
-
Gummidi L, Kerru N, Ebenezer O, Awolade P, Sanni O, Islam MS, Singh P. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through a-glucosidase and a-amylase inhibition. Bioorg Chem. 2021 10; 115:105210. PMID: 34332231.
-
Seboletswe P, Awolade P, Singh P. Recent Developments on the Synthesis and Biological Activities of Fused Pyrimidinone Derivatives. ChemMedChem. 2021 07 06; 16(13):2050-2067. PMID: 33724717.
-
Awolade P, Cele N, Ebenezer O, Kerru N, Gummidi L, Gu L, Palma G, Kaur M, Singh P. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents. Anticancer Agents Med Chem. 2021; 21(10):1228-1239. PMID: 32990543.
-
Kumar S, Gendrot M, Fonta I, Mosnier J, Cele N, Awolade P, Singh P, Pradines B, Kumar V. Amide Tethered 4-Aminoquinoline-naphthalimide Hybrids: A New Class of Possible Dual Function Antiplasmodials. ACS Med Chem Lett. 2020 Dec 10; 11(12):2544-2552. PMID: 33335678.
-
Rani A, Johansen MD, Roquet-Ban?res F, Kremer L, Awolade P, Ebenezer O, Singh P, Kumar V. Design and synthesis of 4-Aminoquinoline-isoindoline-dione-isoniazid triads as potential anti-mycobacterials. Bioorg Med Chem Lett. 2020 11 15; 30(22):127576. PMID: 32980514.
-
Gummidi L, Kerru N, Awolade P, Raza A, Sharma AK, Singh P. Synthesis of indole-tethered [1,3,4]thiadiazolo and [1,3,4]oxadiazolo[3,2-a]pyrimidin-5-one hybrids as anti-pancreatic cancer agents. Bioorg Med Chem Lett. 2020 11 15; 30(22):127544. PMID: 32920143.
-
Awolade P, Cele N, Kerru N, Singh P. Synthesis, antimicrobial evaluation, and in silico studies of quinoline-1H-1,2,3-triazole molecular hybrids. Mol Divers. 2021 Nov; 25(4):2201-2218. PMID: 32507981.
-
Saha ST, Kaur M, Oluwakemi E, Awolade P, Singh P, Kumar V. Synthesis and in vitro anti-proliferative evaluation of naphthalimide-chalcone/pyrazoline conjugates as potential SERMs with computational validation. RSC Adv. 2020 Apr 21; 10(27):15836-15845. PMID: 35493668.
-
Dhawan S, Awolade P, Kisten P, Cele N, Pillay AS, Saha S, Kaur M, Jonnalagadda SB, Singh P. Synthesis, Cytotoxicity and Antimicrobial Evaluation of New Coumarin-Tagged ?-Lactam Triazole Hybrid. Chem Biodivers. 2020 Jan; 17(1):e1900462. PMID: 31788939.
-
Rani A, Kumar S, Legac J, Adeniyi AA, Awolade P, Singh P, Rosenthal PJ, Kumar V. Design, synthesis, heme binding and density functional theory studies of isoindoline-dione-4-aminoquinolines as potential antiplasmodials. Future Med Chem. 2020 02; 12(3):193-205. PMID: 31802710.
-
Awolade P, Cele N, Kerru N, Gummidi L, Oluwakemi E, Singh P. Therapeutic significance of ?-glucuronidase activity and its inhibitors: A review. Eur J Med Chem. 2020 Feb 01; 187:111921. PMID: 31835168.
-
Ebenezer O, Awolade P, Koorbanally N, Singh P. New library of pyrazole-imidazo[1,2-a]pyridine molecular conjugates: Synthesis, antibacterial activity and molecular docking studies. Chem Biol Drug Des. 2020 01; 95(1):162-173. PMID: 31580533.
-
Dhawan S, Kerru N, Awolade P, Singh-Pillay A, Saha ST, Kaur M, Jonnalagadda SB, Singh P. Synthesis, computational studies and antiproliferative activities of coumarin-tagged 1,3,4-oxadiazole conjugates against MDA-MB-231 and MCF-7 human breast cancer cells. Bioorg Med Chem. 2018 11 15; 26(21):5612-5623. PMID: 30360952.
-
Kerru N, Singh-Pillay A, Awolade P, Singh P. Current anti-diabetic agents and their molecular targets: A review. Eur J Med Chem. 2018 May 25; 152:436-488. PMID: 29751237.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
| Year | Publications |
|---|
| 2018 | 2 | | 2019 | 3 | | 2020 | 6 | | 2021 | 5 | | 2022 | 2 | | 2023 | 1 |
To return to the timeline, click here.
|
Awolade's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|